|
Home | Your Profile | Search | About Us | Pricing | Disclaimer |
|
|
|
 |
Home |  |
|
Outsourcing Reports | |
|
Outsourcing Showcase | |
 |
Reports Store |  |
|
Outsourcing Directory | |
|
Events | |
|
Advertising | |
|
News | |
| | Help |
4 Items, CDN $ 1000 |
Go Back  |
|||
Abstract 24 Pages This report highlights emerging opportunities and challenges associated with outsourcing drug discovery and development activities to India. Outsourcing across the Pharmaceutical Value Chain discusses opportunities in drug discovery research, preclinical research, clinical trial study design and management, clinical supplies management, manufacturing, packaging, distribution and even marketing and sales, the outsourcing market size and expected growth, emerging markets, the advantages and challenges associated with outsourcing. The Indian Market including size, growth, therapeutic area targets, the top ten companies in India, policy changes, business models adopted and the outlook are also discussed in this report. The Indian Outsourcing Market has been given a separate section in this report and discusses the Indian cost advantage, the Indian research infrastructure, Western companies outsourcing manufacturing and clinical research to India, the clinical research market size and growth, clinical research outsourcing business models, regulatory reforms to aid clinical research outsourcing, and how to find the right partner. Case Studies include: Abbott AstraZeneca Aventis Bayer Bristol Myers Squibb Eli Lilly GlaxoSmithKline Merck KcGA Novartis Pfizer PPD Aurigene Biocon Clinigene Matrix Quintiles India Shanta Siro Clinpharma Syngene The cases discuss outsourcing partnerships across the pharmaceutical value chain and anticipated new investments and/or opportunities for these companies. Table of Contents Click here to view the Table of Contents | |||
Using the Site Privacy & Security Statement
Advertise with us Directory Guide
CanBiotech Newsletters
© 2000-2010 CanBiotech™ Inc.